Gyre Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 07/08/2026 | Mar 2026Filed 07/08/2026 | Sep 2025Filed 07/11/2025 | Jun 2025Filed 07/08/2026 | Mar 2025Filed 07/08/2026 | Sep 2024Filed 07/11/2025 | Jun 2024Filed 07/11/2025 | Mar 2024Filed 07/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $29 | $23 | $31 | $30 | $22 | $25 | $25 | $27 | |
| −$14 | −$19 | $5.9 | −$2.2 | $4.9 | $2.9 | $4.5 | $9.9 | |
| −$0.12 | −$0.10 | $0.03 | −$0.03 | $0.00 | $0.01 | $0.01 | $0.03 | |
| 101 | 91 | 104 | 89 | 102 | 103 | 102 | 103 |
Trend